MedTrace Logo

Healthy Homes/Healthy Families (HH/HF) Intervention in 2-1-1 Callers

NCT04373434 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 512

Last updated 2025-10-22

Study results available
· View outcomes & findings →

Summary

This trial will evaluate a healthy eating and weight gain prevention intervention for delivery through calls to the 2-1-1 number.

Conditions

  • Weight Change, Body

Interventions

BEHAVIORAL

Health Homes/Healthy Families (HH/HF) Intervention

The HH/HF Intervention involves coaching calls, text messages and intervention materials that are designed to increase behavioral capability, self-efficacy and behavioral intention to improve the home food environment for healthy eating and weight gain prevention. The intervention is delivered over a 12 week period.

BEHAVIORAL

Control

Participants in the control condition will receive two mailings on healthy eating, the first from the "Dietary Guidelines For Americans 2015-2020, 8th Edition" and the second from "Choose MyPlate". Additionally, both mailings will include a food diary from the Centers for Disease Control and Prevention. Mailings will be sent to participants one and six-weeks post-baseline. These materials focus on the same dietary outcomes being targeted in the HH/HF intervention, but without the home environment emphasis. Control group participants will receive their home environment profile with a list of healthy actions upon completion of the study.

Sponsors & Collaborators

Principal Investigators

  • Michelle Kegler, DrPH/MPH · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-18
Primary Completion
2023-08-28
Completion
2023-08-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04373434 on ClinicalTrials.gov